Interleukin-6 and Interleukin-1 receptor antagonist in cerebrospinal fluidfrom patients with recent tonic-clonic seizures

Citation
J. Peltola et al., Interleukin-6 and Interleukin-1 receptor antagonist in cerebrospinal fluidfrom patients with recent tonic-clonic seizures, EPILEPSY R, 41(3), 2000, pp. 205-211
Citations number
32
Categorie Soggetti
Neurology,"Neurosciences & Behavoir
Journal title
EPILEPSY RESEARCH
ISSN journal
09201211 → ACNP
Volume
41
Issue
3
Year of publication
2000
Pages
205 - 211
Database
ISI
SICI code
0920-1211(200010)41:3<205:IAIRAI>2.0.ZU;2-C
Abstract
We have previously reported increased concentrations of interleukin (IL)-6 in CSF from patients with tonic-clonic seizures, where increased cytokine p roduction most likely is a consequence of neuronal epileptic activity assoc iated with seizures. The biological effects of IL-6 are mediated by other c ytokines, which are studied here in addition to IL-6. The purpose of this s tudy was to analyze levels of soluble cytokines from plasma and CSF from pa tients with newly developed tonic-clonic seizures. The concentrations of IL -6, IL-1 receptor antagonist (IL-1RA), IL-1 beta, tumor necrosis factor (TN F alpha) and nerve growth factor (NGF) were measured from plasma and CSF fr om 22 patients with newly developed tonic-clonic seizures within 24 h from the seizure and 18 controls. The mean concentrations of IL-6 were significa ntly increased in CSF (P < 0.001) and plasma (P < 0.01) after tonic-clonic seizures, there was some indication of increased concentrations of IL-IRA a nd no significant change in NGF, IL-1 beta or TNF alpha. Our study shows th at cytokine network is activated in patients after recent tonic-clonic seiz ures. We provide evidence of intrathecal production of IL-6 associated with electrical seizure activity. (C) 2000 Elsevier Science B.V. All rights res erved.